Miro Sciences Ltd (ASX:MSX)
Australia · Delayed Price · Currency is AUD 0.0530
-0.0010 (-1.85%)
At close: Oct 29, 2026
Miro Sciences Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 2.63 | 7.27 | 4.95 | 4.91 | 7.22 |
Short-Term Investments | 2 | - | - | - | - |
Cash & Short-Term Investments | 4.63 | 7.27 | 4.95 | 4.91 | 7.22 |
Cash Growth | -36.28% | 46.66% | 0.86% | -31.93% | -49.05% |
Accounts Receivable | 0.13 | 0.1 | 0.05 | 0.04 | 0.12 |
Receivables | 0.13 | 0.1 | 0.05 | 0.04 | 0.12 |
Prepaid Expenses | 0.04 | 0.03 | 0.04 | 0.05 | 0.06 |
Total Current Assets | 4.8 | 7.4 | 5.04 | 5.01 | 7.4 |
Property, Plant & Equipment | 0.09 | 0 | 0.01 | 0.01 | 0.02 |
Long-Term Investments | 0.03 | - | - | - | - |
Other Intangible Assets | 10.27 | 9.57 | 0.39 | 0.27 | 0.32 |
Total Assets | 15.18 | 16.96 | 5.44 | 5.29 | 7.74 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.27 | 0.15 | 0.08 | 0.59 | 2.17 |
Accrued Expenses | 0.02 | - | 0 | 0.01 | 0.05 |
Current Portion of Leases | 0.05 | - | - | - | - |
Total Current Liabilities | 0.34 | 0.15 | 0.09 | 0.6 | 2.22 |
Long-Term Leases | 0.04 | - | - | - | - |
Total Liabilities | 0.37 | 0.15 | 0.09 | 0.6 | 2.22 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 38.81 | 34.26 | 25.52 | 25.27 | 25.27 |
Retained Earnings | -26.71 | -23.28 | -22.04 | -22.99 | -22.6 |
Comprehensive Income & Other | 2.71 | 5.84 | 1.87 | 2.41 | 2.84 |
Shareholders' Equity | 14.81 | 16.81 | 5.35 | 4.69 | 5.52 |
Total Liabilities & Equity | 15.18 | 16.96 | 5.44 | 5.29 | 7.74 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.09 | - | - | - | - |
Net Cash (Debt) | 4.54 | 7.27 | 4.95 | 4.91 | 7.22 |
Net Cash Growth | -37.48% | 46.66% | 0.86% | -31.93% | -49.05% |
Net Cash Per Share | 0.01 | 0.05 | 0.03 | 0.03 | 0.05 |
Filing Date Shares Outstanding | 389.72 | 332.58 | 144.6 | 143.47 | 143.47 |
Total Common Shares Outstanding | 389.72 | 332.58 | 144.6 | 143.47 | 143.47 |
Working Capital | 4.46 | 7.25 | 4.96 | 4.41 | 5.18 |
Book Value Per Share | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 |
Tangible Book Value | 4.54 | 7.25 | 4.96 | 4.42 | 5.2 |
Tangible Book Value Per Share | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 |